Inventor
SHRIVER ZACHARY
US76 patents
⚠️ This page may combine multiple inventors who share the name “SHRIVER ZACHARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS INST TECHNOLOGY
22 patentsUS6597996B1Jul 22, 2003
Method for indentifying or characterizing properties of polymeric units
MASSACHUSETTS INST TECHNOLOGY133 citations99
US7412332B1Aug 12, 2008
Method for analyzing polysaccharides
MASSACHUSETTS INST TECHNOLOGY56 citations98
US7270815B2Sep 18, 2007
2-O sulfatase compositions and related methods
MASSACHUSETTS INST TECHNOLOGY63 citations98
US7247445B2Jul 24, 2007
2-O sulfatase compositions and methods of hydrolyzing therewith
MASSACHUSETTS INST TECHNOLOGY64 citations98
US7117100B2Oct 3, 2006
Method for the compositional analysis of polymers
MASSACHUSETTS INST TECHNOLOGY75 citations98
US7110889B2Sep 19, 2006
Method for identifying or characterizing properties of polymeric units
MASSACHUSETTS INST TECHNOLOGY74 citations98
US7083937B2Aug 1, 2006
Methods and products related to the analysis of polysaccarides
MASSACHUSETTS INST TECHNOLOGY91 citations98
US7056504B1Jun 6, 2006
Rationally designed heparinases derived from heparinase I and II
MASSACHUSETTS INST TECHNOLOGY80 citations98
US6869789B2Mar 22, 2005
Heparinase III and uses thereof
MASSACHUSETTS INST TECHNOLOGY99 citations98
US7585642B2Sep 8, 2009
Methods for evaluating the quality of a heparin sample
MASSACHUSETTS INST TECHNOLOGY33 citations96
US7504247B2Mar 17, 2009
2-O sulfatase compositions and methods of degradation therewith
MASSACHUSETTS INST TECHNOLOGY44 citations96
US7429474B2Sep 30, 2008
2-O sulfatase compositions and methods of analyzing therewith
MASSACHUSETTS INST TECHNOLOGY44 citations96
US7399604B2Jul 15, 2008
Methods and products related to evaluating the quality of a polysaccharide
MASSACHUSETTS INST TECHNOLOGY46 citations96
US7396824B2Jul 8, 2008
2-O sulfatase nucleic acid compositions
MASSACHUSETTS INST TECHNOLOGY50 citations96
US7139666B2Nov 21, 2006
Method for identifying or characterizing properties of polymeric units
MASSACHUSETTS INST TECHNOLOGY62 citations96
US7390633B2Jun 24, 2008
Methods for preparing low molecular weight heparin with modified heparinase III
MASSACHUSETTS INST TECHNOLOGY53 citations95
US7687479B2Mar 30, 2010
Methods and producing low molecular weight heparin
MASSACHUSETTS INST TECHNOLOGY10 citations92
US7560106B2Jul 14, 2009
Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
MASSACHUSETTS INST TECHNOLOGY48 citations92
US7455986B2Nov 25, 2008
Heparinase III and methods of specifically cleaving therewith
MASSACHUSETTS INST TECHNOLOGY32 citations92
US7695711B2Apr 13, 2010
Δ 4,5 glycuronidase nucleic acid compositions
MASSACHUSETTS INST TECHNOLOGY16 citations91
US7951560B2May 31, 2011
Delta 4,5 glycuronidase compositions and methods related thereto
MASSACHUSETTS INST TECHNOLOGY13 citations82
US7939292B2May 10, 2011
Modified heparinase III and methods of sequencing therewith
MASSACHUSETTS INST TECHNOLOGY2 citations62
VISTERRA INC
13 patentsUS9212217B2Dec 15, 2015
Antibody molecules to dengue virus and uses thereof
VISTERRA INC14 citations92
US9096657B2Aug 4, 2015
HA binding agents
VISTERRA INC13 citations92
US8877200B2Nov 4, 2014
HA binding agents
VISTERRA INC17 citations92
US10800835B2Oct 13, 2020
HA binding agents
VISTERRA INC4 citations84
US9969794B2May 15, 2018
HA binding agents
VISTERRA INC7 citations84
US10155806B2Dec 18, 2018
Antibody molecules to dengue virus and uses thereof
VISTERRA INC4 citations83
US9365639B2Jun 14, 2016
Antibody molecules to dengue virus and uses thereof
VISTERRA INC9 citations83
US11059883B2Jul 13, 2021
Antibody molecules to dengue virus and uses thereof
VISTERRA INC2 citations72
US11912781B2Feb 27, 2024
Humanized complement 5A receptor 1 antibodies and methods of use thereof
VISTERRA INC1 citations71
US10513553B2Dec 24, 2019
Compositions and methods for treating and preventing influenza
VISTERRA INC6 citations67
US11230593B2Jan 25, 2022
Compositions and methods for treating and preventing influenza
VISTERRA INC4 citations63
US12054539B2Aug 6, 2024
Antibody molecules to dengue virus and uses thereof
VISTERRA INC0 citations62
US12024552B2Jul 2, 2024
Ha binding agents
VISTERRA INC0 citations62
MOMENTA PHARMACEUTICALS INC
8 patentsUS7575886B2Aug 18, 2009
Analysis of sulfated polysaccharides
MOMENTA PHARMACEUTICALS INC68 citations95
US7968082B1Jun 28, 2011
Evaluating mixtures of low molecular weight heparins by NMR
MOMENTA PHARMACEUTICALS INC24 citations91
US7884187B2Feb 8, 2011
Analysis of amino acid copolymer compositions
MOMENTA PHARMACEUTICALS INC15 citations91
US7790466B1Sep 7, 2010
Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
MOMENTA PHARMACEUTICALS INC15 citations91
US8592142B2Nov 26, 2013
Analysis of amino acid copolymer compositions
MOMENTA PHARMACEUTICALS INC5 citations83
US9085796B2Jul 21, 2015
Analysis of amino acid copolymer compositions
MOMENTA PHARMACEUTICALS INC4 citations82
US7816144B1Oct 19, 2010
Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
MOMENTA PHARMACEUTICALS INC10 citations82
US8921116B2Dec 30, 2014
Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetate
MOMENTA PHARMACEUTICALS INC5 citations81
SHRIVER ZACHARY
4 patentsUS8101733B1Jan 24, 2012
Methods of evaluating mixtures of polysaccharides
SHRIVER ZACHARY9 citations83
US8470603B2Jun 25, 2013
Methods of evaluating diethylamide in glatiramer acetate
SHRIVER ZACHARY6 citations82
US8076149B1Dec 13, 2011
Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
SHRIVER ZACHARY7 citations82
US8609632B2Dec 17, 2013
Low molecular weight heparin composition and uses thereof
SHRIVER ZACHARY6 citations68
COLLINS BRIAN EDWARD
1 patentZHU XIANGPING
1 patentBOSQUES CARLOS J
1 patentShowing the top 50 of 76 patents by PatentIndex Score.